Are we near an acquisition deal?

Explainer on why it matters for financial analysts to cover biotech stocks

Illumina and Oxford Nanopore as main contenders in this field

Guardant Health, Senticell and Heidelberg Epignostix updates

And other news in NGS and Multiomics

What do the competitors have to offer in this new world of personalized cancer vaccines?

Contribute to Shoaib-CS/Adaptive-Banding-Needleman-Wunsch-PLM development by creating an account on GitHub.

NGS and Multiomics news -- 25th August 2026

And other news in NGS, Liquid Biopsy, Single Cell Multiomics and other fields

Biotech is given an AI-bump in recent trading sessions

Overcoming the limitations of blood-based cfDNA Liquid Biopsy with EpiAmp

And more announcements from both companies

AlphaFold3 has shown promise as a tool for predicting antibody-antigen binding, yet its performance across large datasets has not been fully characterized. In this study, 3401 experimentally validated...

This is the best reported quarter Illumina has printed in three years, and almost none of it came from the line that is supposed to carry the story.

What would happen if the AI bubble were to burst tomorrow?

And what it means for Cancer Diagnostics, Liquid Biopsy and Early Cancer Screening

Molecular dynamics (MD) provides a principled method for modeling equilibrium protein conformational energy landscapes, but its computational cost limits access to long timescales and larger protein s...

And what it means for the NGS and Multiomics segment moving forward

Are we moving into a new world where Multiomics and AI can help develop diagnostics tests at a fraction of the time than before?

Updated test version achieved significant performance improvement in detecting advanced precancerous lesions, including those with high-grade dysplasia

Aligned Bio new Nanowire Sequencing Technology, and other pieces of NGS and Multiomics news around the world